Library
Compound Library The reference, by Bangkok Peptides.
A serial editorial reference for the most actively studied research peptides in current scientific literature. Each entry is a deep dive — mechanism, trial data, comparative pharmacology, and citations — produced for researchers who want depth before they buy.
Most peptide vendors will sell you a vial. Few can explain the molecule inside it. The Compound Library is our answer to that gap — a place to understand what’s in the bottle before you commit to buying it.
Published Volumes
01 of 05 in production
Retatrutide
Triple-receptor agonist — GLP-1 + GIP + GCGR
The first peptide to engage three metabolic receptors simultaneously. In published Phase 2 data, retatrutide produced a 24.2% mean body weight reduction at 48 weeks — the largest signal ever recorded in a Phase 2 obesity trial. A complete reference covering mechanism, dose-response data, comparative pharmacology, and selected literature.
Read Volume I →In Production
BPC-157
Body protection compound — pentadecapeptide
The most cited peptide in published tissue repair literature. Mechanism, GI mucosal research, angiogenic pathway studies, and the BPC + TB-500 pairing.
In ProductionTB-500
Thymosin Beta-4 — full 43-residue sequence
The complete Thymosin Beta-4 molecule, not the partial fragment most vendors supply. Actin sequestration, cell migration, and the systemic repair signal.
In ProductionGHK-Cu
Copper Tripeptide-1 — Gly-His-Lys + Cu²⁺
The naturally-occurring tripeptide bound to copper. Cellular signalling, gene-expression research, and the molecular basis for skin and hair studies.
In ProductionIpamorelin
Selective GH secretagogue — Aib-His-D-2-Nal-D-Phe-Lys
The first selective ghrelin/GHS receptor agonist. Why selectivity matters, the Raun et al. 1998 reference, and the GH-pathway research footprint.
In ProductionEvery Compound Library entry is researched against primary peer-reviewed literature, structured to clinical-publication conventions, and reviewed before release. Citations are real. Trial data is verifiable. Pharmacology is cross-referenced. Where the published research is inconclusive, we say so.
We don’t shortcut this work because it’s how we’d want a serious supplier to communicate with us — and because the alternative is the marketing veneer that our market has more than enough of already.
Browse the Catalogue →
